SLU-PP-332 emerged from research conducted at Saint Louis University School of Medicine, where scientists set out to create a compound that could activate the same metabolic pathways triggered by aerobic exercise. The result was a small molecule that acts as a potent agonist for estrogen-related receptors, specifically targeting ERR alpha, beta, and gamma subtypes with varying degrees of potency.https://www.giantrawsource.com/raw-steroid-powder/raws-powder-slupp-332.html
The compound demonstrates particular affinity for ERR alpha, with cell-based assays showing an EC50 of approximately 98 nanomolar. ERR beta activation follows at around 230 nanomolar, while ERR gamma responds at roughly 430 nanomolar. This pan-agonist profile means the compound influences all three receptor subtypes, though its effects on ERR alpha appear most pronounced and likely drive the majority of observed benefits.When SLU-PP-332 binds to these receptors, it initiates a cascade of genetic changes that mirror what happens during sustained aerobic activity. The compound essentially flips genetic switches that your body normally only activates after weeks of consistent endurance training. This includes upregulation of genes controlling mitochondrial biogenesis, fatty acid oxidation pathways, and glucose transporter expression.
How SLU-PP-332 Works
Receptor Activation: Selectively binds to and activates estrogen-related orphan receptors (ERRs), primarily ERRα, which control cellular energy and metabolism.
Mitochondrial Boost: Promotes mitochondrial biogenesis (creating more cellular power plants) and enhances cellular respiration in skeletal muscle.
Metabolic Shift:
Reprograms the body to preferentially burn fatty acids for fuel, increasing overall energy expenditure and reducing fat mass accumulation at rest.
